Adicet Bio, Inc. (ACET)
4.57
-0.57
(-11.09%)
USD |
NASDAQ |
Oct 16, 16:00
4.60
+0.03
(+0.66%)
After-Hours: 20:00
Adicet Bio Price to Book Value : 0.3561 for Oct. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 16, 2026 | 0.3561 |
| October 15, 2026 | 0.4005 |
| October 14, 2026 | 0.381 |
| October 13, 2026 | 0.3982 |
| October 12, 2026 | 0.4309 |
| October 09, 2026 | 0.4371 |
| October 08, 2026 | 0.4473 |
| October 07, 2026 | 0.4816 |
| October 06, 2026 | 0.487 |
| October 05, 2026 | 0.5042 |
| October 02, 2026 | 0.5065 |
| October 01, 2026 | 0.5174 |
| September 30, 2026 | 0.5564 |
| September 29, 2026 | 0.5322 |
| September 28, 2026 | 0.4948 |
| September 25, 2026 | 0.7029 |
| September 24, 2026 | 0.6444 |
| September 23, 2026 | 0.6616 |
| September 22, 2026 | 0.7126 |
| September 21, 2026 | 0.6958 |
| September 18, 2026 | 0.7153 |
| September 17, 2026 | 0.7021 |
| September 16, 2026 | 0.7052 |
| September 15, 2026 | 0.6627 |
| September 14, 2026 | 0.7558 |
| Date | Value |
|---|---|
| September 11, 2026 | 0.7418 |
| September 10, 2026 | 0.7426 |
| September 09, 2026 | 0.7434 |
| September 08, 2026 | 0.7582 |
| September 04, 2026 | 0.7473 |
| September 03, 2026 | 0.7348 |
| September 02, 2026 | 0.7216 |
| September 01, 2026 | 0.7216 |
| August 31, 2026 | 0.6779 |
| August 28, 2026 | 0.706 |
| August 27, 2026 | 0.7021 |
| August 26, 2026 | 0.6974 |
| August 25, 2026 | 0.7013 |
| August 24, 2026 | 0.6935 |
| August 21, 2026 | 0.7161 |
| August 20, 2026 | 0.7309 |
| August 19, 2026 | 0.7395 |
| August 18, 2026 | 0.7099 |
| August 17, 2026 | 0.681 |
| August 14, 2026 | 0.653 |
| August 13, 2026 | 0.6436 |
| August 12, 2026 | 0.6436 |
| August 11, 2026 | 0.6413 |
| August 10, 2026 | 0.6319 |
| August 07, 2026 | 0.6218 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.519 |
| Alnylam Pharmaceuticals, Inc. | 22.90 |
| Anika Therapeutics, Inc. | 1.948 |
| Savara, Inc. | 6.362 |
| Vericel Corp. | 5.549 |
Price to Book Value Related Metrics
| PEG Ratio | -0.1287 |
| Price | 4.57 |
| Earnings Yield | -252.4% |
| Market Cap | 42.78M |
| PEGY Ratio | -0.1287 |